STEPHANIE TAYLOR: Open Payments
NPI 1750033957 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,059 in 103 payments from 15 companies in 2025. Trend: 2023 $1,614 · 2024 $846 · 2025 $2,059
Food & beverage: $2,038Education: $20
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $296 |
| Amgen Inc. | 18 | $289 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $225 |
| PFIZER INC. | 11 | $225 |
| Novo Nordisk Inc | 8 | $221 |
| BridgeBio Pharma, Inc. | 3 | $175 |
| Merck Sharp & Dohme LLC | 12 | $170 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $122 |
| Boston Scientific Corporation | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
Products named: Kerendia, REPATHA, JARDIANCE, Attruby, VERQUVO, ELIQUIS, VYNDAQEL, LifeVest.
Industry payments across IN — which companies pay providers there.
